(Health-NewsWire.Net, June 16, 2018 ) This report studies the global Gene Therapy market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Gene Therapy market by companies, region, type and end-use industry.
Gene therapy is an experimental treatment that involves introducing genetic material into a person's cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a "vector." The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy. Gene therapy is a method that involves introducing genetic material into a person's cells to fight or prevent diseases. In recent decades of years, researchers are paying more and more attention on it. Until today, it is still in infancy. There are many bio-technology companies entered into this market and carry on related research and development.
These research companies are including Bluebird Bio, Sangamom, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical and Advantagene. Among them, the top 5 research companies occupied more than 85% market.
Generally, the research fees of companies are come from their collaboration partners. For example, Bayer Healthcare is the partner of Dimension Therapeutics. General, some products of these companies are in the period 3 of their pipeline.
In general, cancer diseases are still the largest application with market share over 65% in 2015. In addition, there are some companies are focus on rare diseases.
This report studies the global Gene Therapy market, analyzes and researches the Gene Therapy development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Bluebird Bio Sangamo Spark Therapeutics Dimension Therapeutics Avalanche Bio Celladon Vical Inc. Advantagene
FREE | sample of report @ http://www.reportsweb.com/inquiry&RW00012075221/sample
Market segment by Type, the product can be split into Ex vivo In Vivo
Market segment by Application, split into Cancer Monogenic Infectious disease Cardiovascular disease Other
Browse Complete Report @ http://www.reportsweb.com/global-gene-therapy-market-size-status-and-forecast-2018-2025
The study objectives of this report are: To study and forecast the market size of Gene Therapy in global market. To analyze the global key players, SWOT analysis, value and global market share for top players. To define, describe and forecast the market by type, end use and region. To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World. To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks. To identify significant trends and factors driving or inhibiting the market growth. To analyze the opportunities in the market for stakeholders by identifying the high growth segments. To strategically analyze each submarket with respect to individual growth trend and their contribution to the market To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market To strategically profile the key players and comprehensively analyze their growth strategies.
Ask for Discount on Report @ http://www.reportsweb.com/inquiry&RW00012075221/discount
Table of Content
Global Gene Therapy Market Size, Status and Forecast 2025 1 Industry Overview of Gene Therapy
2 Global Gene Therapy Competition Analysis by Players
3 Company (Top Players) Profiles 3.1 Bluebird Bio 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Gene Therapy Revenue (Million USD) (2013-2018) 3.2 Sangamo 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Gene Therapy Revenue (Million USD) (2013-2018) 3.3 Spark Therapeutics 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Gene Therapy Revenue (Million USD) (2013-2018) 4 Global Gene Therapy Market Size by Type and Application (2013-2018)
5 United States Gene Therapy Development Status and Outlook
6 EU Gene Therapy Development Status and Outlook
7 Japan Gene Therapy Development Status and Outlook
8 China Gene Therapy Development Status and Outlook
9 India Gene Therapy Development Status and Outlook
10 Southeast Asia Gene Therapy Development Status and Outlook
11 Market Forecast by Regions, Type and Application (2018-2025)
12 Gene Therapy Market Dynamics
13 Market Effect Factors Analysis
Place Direct Purchase order For Complete report @ http://www.reportsweb.com/buy&RW00012075221/buy/3300
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|